Total Holdings
66
Portfolio diversification across 66 positions
XPH
(NYSEARCA)State Street SPDR S&P Pharmaceuticals ETF
$69.32-- (--)
Loading... - Market loading
XPH ETF Holdings: State Street SPDR S&P Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$478.93M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
State Street
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Corcept Therapeutics Incorporated | Stock | 4.36% |
| 2 |  | Organon & Co. | Stock | 3.71% |
| 3 |  | Crinetics Pharmaceuticals, Inc. | Stock | 3.65% |
| 4 |  | Liquidia Corporation | Stock | 3.28% |
| 5 |  | MBX Biosciences, Inc. | Stock | 2.89% |
| 6 |  | AtaiBeckley Inc. | Stock | 2.84% |
| 7 |  | Axsome Therapeutics, Inc | Stock | 2.81% |
| 8 |  | Definium Therapeutics, Inc. | Stock | 2.70% |
| 9 |  | Enliven Therapeutics Inc. | Stock | 2.32% |
| 10 |  | Amneal Pharmaceuticals, Inc | Stock | 2.27% |
| 11 |  | Jazz Pharmaceuticals plc | Stock | 2.25% |
| 12 |  | Nuvation Bio Inc. | Stock | 2.18% |
| 13 |  | Amylyx Pharmaceuticals, Inc. | Stock | 2.17% |
| 14 |  | Harmony Biosciences Holdings Inc | Stock | 2.16% |
| 15 |  | Royalty Pharma plc | Stock | 2.09% |
| 16 |  | Esperion Therapeutics, Inc | Stock | 2.07% |
| 17 |  | Viatris Inc | Stock | 2.06% |
| 18 |  | Eli Lilly and Company | Stock | 2.05% |
| 19 |  | Trevi Therapeutics, Inc. | Stock | 2.05% |
| 20 |  | Ligand Pharmaceuticals Incorporated | Stock | 2.03% |
| 21 |  | Xeris Pharmaceuticals Inc | Stock | 2.02% |
| 22 |  | Alumis Inc. | Stock | 2.01% |
| 23 |  | Perrigo Company plc | Stock | 1.96% |
| 24 |  | Edgewise Therapeutics Inc | Stock | 1.93% |
| 25 |  | ANI Pharmaceuticals, Inc | Stock | 1.89% |
| 26 |  | Nektar Therapeutics | Stock | 1.86% |
| 27 |  | Merck & Co., Inc | Stock | 1.84% |
| 28 |  | Elanco Animal Health Incorporated | Stock | 1.81% |
| 29 |  | Pacira BioSciences, Inc | Stock | 1.81% |
| 30 |  | Harrow Health Inc | Stock | 1.80% |
| 31 |  | Veradermics, Incorporated | Stock | 1.79% |
| 32 |  | Innoviva, Inc | Stock | 1.77% |
| 33 |  | Johnson & Johnson | Stock | 1.73% |
| 34 |  | Bristol-Myers Squibb Company | Stock | 1.71% |
| 35 |  | Collegium Pharmaceutical Inc | Stock | 1.70% |
| 36 |  | Pfizer Inc | Stock | 1.69% |
| 37 |  | Maze Therapeutics, Inc. | Stock | 1.69% |
| 38 |  | Omeros Corporation | Stock | 1.65% |
| 39 |  | Ocular Therapeutix Inc | Stock | 1.62% |
| 40 |  | Tarsus Pharmaceuticals Inc | Stock | 1.58% |
| 41 |  | Supernus Pharmaceuticals, Inc | Stock | 1.51% |
| 42 |  | CorMedix Inc | Stock | 1.49% |
| 43 |  | Eyepoint Pharmaceuticals Inc | Stock | 1.48% |
| 44 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.42% |
| 45 |  | Amphastar Pharmaceuticals, Inc | Stock | 1.40% |
| 46 |  | Theravance Biopharma Inc | Stock | 1.33% |
| 47 |  | Septerna, Inc. Common Stock | Stock | 1.31% |
| 48 |  | Prestige Consumer Healthcare Inc | Stock | 1.30% |
| 49 | K KMPH | KemPharm Inc | Stock | 1.26% |
| 50 |  | Phathom Pharmaceuticals, Inc | Stock | 1.23% |
Frequently Asked Questions About State Street SPDR S&P Pharmaceuticals ETF Holdings
What are the top holdings in XPH?
State Street SPDR S&P Pharmaceuticals ETF (XPH) holds 66 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is XPH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review XPH's holdings table to analyze concentration risk.
What is XPH's sector allocation?
The Sector Allocation chart shows how XPH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does XPH invest in?
XPH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is XPH ETF?
XPH's diversification can be assessed by reviewing its 66 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.